{"id":"tranexamic-acid-plus-standard-of-care","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolic events (deep vein thrombosis, pulmonary embolism)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Visual disturbances"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Tranexamic Acid plus standard of care","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:09:19.269683+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:09:24.556084+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Tranexamic Acid plus standard of care","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:09:24.904270+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Plasminogen inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:09:36.743501+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL877/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:09:36.403040+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tranexamic acid is an antifibrinolytic agent that competitively inhibits the binding of plasminogen and plasmin to fibrin, preventing the breakdown of blood clots. By reducing fibrinolysis, it helps maintain hemostasis and reduce blood loss in surgical and trauma settings. When combined with standard of care, it enhances the overall hemostatic effect in clinical scenarios where excessive bleeding is a concern.","oneSentence":"Tranexamic acid inhibits fibrinolysis by blocking plasminogen activation, thereby reducing bleeding and promoting clot stability.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:43.575Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:09:37.974569+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Reduction of blood loss in surgical procedures"},{"name":"Treatment of bleeding in trauma patients"},{"name":"Prevention of excessive bleeding in hemophilia patients undergoing surgery"}]},"trialDetails":[{"nctId":"NCT07033039","phase":"NA","title":"Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2026-01-30","conditions":"Rhinoplasty, Edema","enrollment":60},{"nctId":"NCT03128866","phase":"EARLY_PHASE1","title":"Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-05-19","conditions":"Pelvic Mass","enrollment":80},{"nctId":"NCT07434453","phase":"NA","title":"\"Topical Tranexamic Acid With Flap Fixation: A Novel Approach to Minimize Post-operative Drainage and Surgical Site Infection in Patients Undergoing Modified Radical Mastectomy\"","status":"COMPLETED","sponsor":"Noor ul Ain","startDate":"2023-08-04","conditions":"Breast Cancer Females","enrollment":62},{"nctId":"NCT07410130","phase":"","title":"Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-03","conditions":"Von Willebrand Disease (VWD), Inherited Bleeding Disorders in Children, Pediatric Hemostatic Disorders","enrollment":25},{"nctId":"NCT07362992","phase":"EARLY_PHASE1","title":"Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2026-01-01","conditions":"Cesarean Delivery, Postpartum Hemorrhage (PPH), Intraoperative Blood Loss","enrollment":112},{"nctId":"NCT05345613","phase":"PHASE4","title":"Tranexamic Acid During Colonic Endoscopic Resection Procedures","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2022-05-01","conditions":"Colon Neoplasm","enrollment":200},{"nctId":"NCT05075200","phase":"PHASE2","title":"Tranexamic Acid Dosing for Major Joint Replacement Surgery","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2021-12-14","conditions":"Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip","enrollment":21},{"nctId":"NCT05441592","phase":"PHASE4","title":"A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2022-08-15","conditions":"Hematoma Postoperative","enrollment":107},{"nctId":"NCT04811313","phase":"NA","title":"Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-04-03","conditions":"Intraoperative Blood Loss, Pediatric, Orthopedic Disorder","enrollment":400},{"nctId":"NCT06057675","phase":"PHASE2","title":"Tranexamic Acid in Nasal Mohs Reconstruction","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-03-19","conditions":"Postoperative Bleeding, Skin Cancer Face","enrollment":100},{"nctId":"NCT05713630","phase":"PHASE3","title":"The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma","status":"NOT_YET_RECRUITING","sponsor":"Unity Health Toronto","startDate":"2025-09-30","conditions":"Subdural Hematoma","enrollment":130},{"nctId":"NCT06128330","phase":"PHASE4","title":"Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-12-15","conditions":"Antifibrinolytic Agents","enrollment":322},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT04625530","phase":"PHASE3","title":"Perioperative Management in Gynaecological Carcinoma Surgery","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-08-01","conditions":"Gynaecological Carcinoma","enrollment":""},{"nctId":"NCT06384456","phase":"PHASE4","title":"Topical TRanexamic Acid Vs. Placebo on Acute Postoperative Pain Following DRF Fixation","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-03","conditions":"Distal Radius Fractures","enrollment":90},{"nctId":"NCT06648369","phase":"NA","title":"Maximal Medical Treatment of Intracerebral Haemorrhage Pilot Trial - MAX-ICH Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-12-01","conditions":"Intra Cerebral Hemorrhage","enrollment":50},{"nctId":"NCT06622564","phase":"PHASE3","title":"Decreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid 2 Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-01-01","conditions":"Bleeding, Surgical Blood Loss, Seizures","enrollment":40},{"nctId":"NCT06509256","phase":"EARLY_PHASE1","title":"Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-20","conditions":"Pharmacological-Aggravated Urticaria","enrollment":50},{"nctId":"NCT03517098","phase":"NA","title":"Enhanced Recovery After Surgery (ERAS) Pathway for Primary Hip and Knee Arthroplasty","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2021-02-01","conditions":"Arthroplasty, Replacement, Hip, Knee","enrollment":640},{"nctId":"NCT03780894","phase":"PHASE1, PHASE2","title":"Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2018-11-21","conditions":"Polytrauma, Traumatic Hemorrhage","enrollment":79},{"nctId":"NCT05382403","phase":"NA","title":"Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-10-23","conditions":"Postpartum Hemorrhage, Maternal Death","enrollment":424},{"nctId":"NCT04149171","phase":"PHASE3","title":"Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage","status":"COMPLETED","sponsor":"Cristina Martinez","startDate":"2018-09-26","conditions":"Hemorrhagic Shock","enrollment":30},{"nctId":"NCT05672407","phase":"PHASE4","title":"The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery","status":"WITHDRAWN","sponsor":"University of Miami","startDate":"2023-09-01","conditions":"Eyelid Diseases, Periorbital Disorder, Hemorrhage","enrollment":""},{"nctId":"NCT05639686","phase":"NA","title":"TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality","status":"UNKNOWN","sponsor":"Our Lady of the Lake Hospital","startDate":"2023-01-01","conditions":"Rhinosinusitis Chronic, Sinus Cancer, Sinus Polyp","enrollment":100},{"nctId":"NCT01869413","phase":"PHASE2, PHASE3","title":"Tranexamic Acid During Cystectomy Trial (TACT)","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2013-06","conditions":"Bladder Cancer","enrollment":354},{"nctId":"NCT02053363","phase":"PHASE2, PHASE3","title":"Tranexamic Acid Dosing in Adult Spinal Deformity Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2014-03","conditions":"Adult Spinal Deformity","enrollment":64},{"nctId":"NCT03690037","phase":"PHASE4","title":"Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty","status":"COMPLETED","sponsor":"Belfast Health and Social Care Trust","startDate":"2016-07-07","conditions":"Primary Total Knee Arthroplasty, Primary Total Hip Arthroplasty","enrollment":1089},{"nctId":"NCT04804345","phase":"","title":"AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2021-03-31","conditions":"Cardiac Surgery, Cardiopulmonary Bypass, High Risk Bleeding","enrollment":693},{"nctId":"NCT04907812","phase":"PHASE4","title":"The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery","status":"UNKNOWN","sponsor":"Ruby Grewal","startDate":"2021-06-01","conditions":"Hand Injuries and Disorders, Distal Radius Fracture, Dupuytren Contracture","enrollment":50},{"nctId":"NCT04788121","phase":"PHASE3","title":"Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2020-11-01","conditions":"Gastro Intestinal Bleeding","enrollment":160},{"nctId":"NCT02655653","phase":"PHASE3","title":"Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2008-10","conditions":"Bleeding","enrollment":114},{"nctId":"NCT02278263","phase":"PHASE4","title":"Tranexamic Acid in Knee Joint Surgery","status":"COMPLETED","sponsor":"Andrew G Hill, MBChB, MD (Thesis), EdD, FACS, FRACS","startDate":"2014-12","conditions":"Osteoarthritis","enrollment":150},{"nctId":"NCT01940523","phase":"PHASE4","title":"Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2013-05","conditions":"Osteoarthritis","enrollment":640},{"nctId":"NCT03888768","phase":"NA","title":"ProPBM : A Modified Patient Blood Management Protocol","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2019-08-01","conditions":"Iron-deficiency","enrollment":180},{"nctId":"NCT02579941","phase":"NA","title":"Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.","status":"COMPLETED","sponsor":"Brugmann University Hospital","startDate":"2015-11","conditions":"Hyperfibrinolysis","enrollment":40},{"nctId":"NCT01895101","phase":"PHASE4","title":"The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Amphia Hospital","startDate":"2013-10","conditions":"Blood Loss, Tranexamic Acid, Cardiac Surgery","enrollment":750},{"nctId":"NCT02071316","phase":"NA","title":"The Use of Hexacapron in Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2014-04","conditions":"Upper Gastrointestinal Bleeding, Hexacapron, Hemostasis","enrollment":300},{"nctId":"NCT01655641","phase":"PHASE2, PHASE3","title":"Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery","status":"UNKNOWN","sponsor":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","startDate":"2012-07","conditions":"Gastric Cancer, Pancreatic Cancer, Hepatocellular Cancer","enrollment":118},{"nctId":"NCT00827931","phase":"PHASE4","title":"Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-09","conditions":"Biliary Tract Surgical Procedures, Pancreaticoduodenectomy, Esophagectomy","enrollment":94},{"nctId":"NCT01260818","phase":"NA","title":"Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine","startDate":"2010-12","conditions":"Hip Replacement, Postoperative Hemorrhage","enrollment":100},{"nctId":"NCT00824564","phase":"PHASE4","title":"Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-04","conditions":"Femoral Fractures","enrollment":82}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL877"},"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tranexamic Acid plus standard of care","genericName":"Tranexamic Acid plus standard of care","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tranexamic acid inhibits fibrinolysis by blocking plasminogen activation, thereby reducing bleeding and promoting clot stability. Used for Reduction of blood loss in surgical procedures, Treatment of bleeding in trauma patients, Prevention of excessive bleeding in hemophilia patients undergoing surgery.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:09:37.974569+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}